Risk of Production Suspensions and Business Performance Fluctuations Due to COVID-19
First written in FY2020. 10 of 14 entries say "Restated". Latest entry: FY2024.
The whole theme swung hardest in 2024: 6 of 14 companies on the "Worse" side.
2 other companies' latest entry also says "Softened".
- FY2024SoftenedAnnual report
「If the number of people infected with viral diseases among the Company's employees or business partners increases, the Company may substantially affect its operating results and financial condition by temporarily reducing or suspending its production operations, among other measures.」
Infectious disease risk continued to be disclosed, but the wording changed from "COVID-19" to the general term "viral diseases," and the economic outlook reflected the view that the impact of the COVID-19 pandemic had subsided. - FY2024-Q3RestatedAnnual report
「The Company will continue to closely monitor developments concerning the impact of COVID-19 on the Company and other related matters. However, the timing of the containment of the disease and developments in other circumstances may affect the Company's operating results and financial condition.」
The risk assessment that the timing of the end of COVID-19 and how circumstances develop may affect business performance and financial condition has continued. - FY2024-Q1RestatedAnnual report
「We will continue to closely monitor developments concerning the impact of COVID-19 on the Company, but business performance and financial condition may be affected depending on when the disease ends and how other circumstances develop.」
The risk assessment that the timing of the end of COVID-19 and how circumstances develop may affect business performance and financial condition has continued. - FY2023SoftenedAnnual report
「After 3 years of COVID-19, restrictions were gradually lifted in various countries, and Japan shifted the disease's classification under the Infectious Diseases Act from Category II to Category V, bringing daily life into a state of living with COVID-19.」
Infectious disease risk itself continues to be listed as a business risk, but the lifting of restrictions in various countries and Japan's shift to Category V have softened the description of the external environment compared with before. - FY2023-Q3RestatedAnnual report
「The Company will continue to closely monitor developments concerning the impact of COVID-19 on the Company and other related matters. However, the timing of the containment of the disease and developments in other circumstances may affect the Company's operating results and financial condition.」
The risk that the timing of the containment of COVID-19 and developments in the situation could affect operating results and financial condition was reaffirmed. - FY2023-Q2RestatedAnnual report
「We will continue to closely monitor developments concerning the impact of COVID-19 on the Company, but our business performance and financial condition may be affected depending on when the disease ends and how other circumstances develop.」
It was reconfirmed that business performance and financial condition may fluctuate depending on when COVID-19 ends and how circumstances develop. - FY2023-Q1RestatedAnnual report
「We will continue to closely monitor developments concerning the impact of COVID-19 on the Company, but business performance and financial condition may be affected depending on when the disease ends and how other circumstances develop.」
The risk assessment that the timing of the end of COVID-19 and how circumstances develop may affect business performance and financial condition has continued. - FY2022-Q3RestatedAnnual report
「We will continue to closely monitor developments concerning the impact of COVID-19 on the Company, but our business performance and financial condition may be affected depending on when the disease ends and how other circumstances develop.」
It was reconfirmed that business performance and financial condition may fluctuate depending on when COVID-19 ends and how circumstances develop. - FY2022-Q2RestatedAnnual report
「We will continue to closely monitor developments concerning the impact of COVID-19 on the Company, but our business performance and financial condition may be affected depending on when the disease ends and how other circumstances develop.」
It was reconfirmed that business performance and financial condition may fluctuate depending on when COVID-19 ends and how circumstances develop. - FY2022-Q1WorsenedAnnual report
「The economic environment in the first quarter had repeatedly fluctuated as infection levels of COVID-19 ebbed and flowed, but the Delta variant has caused an unprecedented surge in infections.」
The unprecedented surge in infections caused by the Delta variant was reported in connection with COVID-19, increasing the risks related to the containment of infections and the impact on business performance. - FY2021-Q3RestatedAnnual report
「We will continue to closely monitor developments concerning the impact of COVID-19 on the Company, but our business performance and financial condition may be affected depending on when the disease ends and how other circumstances develop.」
It was reconfirmed that business performance and financial condition may fluctuate depending on when COVID-19 ends and how circumstances develop. - FY2021-Q2RestatedAnnual report
「We will continue to closely monitor developments concerning the impact of COVID-19 on the Company, but our business performance and financial condition may be affected depending on when the disease ends and how other circumstances develop.」
It was reconfirmed that business performance and financial condition may fluctuate depending on when COVID-19 ends and how circumstances develop. - FY2021-Q1RestatedAnnual report
「We will continue to closely monitor developments concerning the impact of COVID-19 on the Company, but our business performance and financial condition may be affected depending on when the disease ends and how other circumstances develop.」
It was reconfirmed that business performance and financial condition may fluctuate depending on when COVID-19 ends and how circumstances develop. - FY2020First statedAnnual report
「If a state of emergency is declared again or a COVID-19 infection occurs among our employees or business partners, our business performance and financial condition could be materially affected, including through the temporary scaling back or suspension of our production operations.」
COVID-19 was first described as a standalone business and other risk. The risk has materialized, as delays in orders for large-scale projects for China and interruptions to projects under discussion have already occurred.